Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management

Checkpoint inhibitors can cause an imbalance in immune tolerance that may clinically manifest as immune-related adverse events (irAEs). These events may involve many organs and tissues, including the skin, gastrointestinal (GI) tract, liver, endocrine system, kidneys, central nervous system (CNS), e...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Melanoma Manag
Autori principali: Simeone, Ester, Grimaldi, Antonio M, Festino, Lucia, Trojaniello, Claudia, Vitale, Maria G, Vanella, Vito, Palla, Marco, Ascierto, Paolo A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Future Medicine Ltd 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920742/
https://ncbi.nlm.nih.gov/pubmed/31871619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi